The White House says the United States will share up to 60 million doses of its AstraZeneca vaccine with other countries.
The doses will be available for export in the coming months following a federal security review.
The United States has stockpiles of the vaccine, although its regulators have not yet authorized it for public use.
Critics accuse the government of stockpiling the vaccine, while other countries are in dire need.
Last month, President Biden promised to share about four million doses of the AstraZeneca vaccine with Mexico and Canada, both of which confirmed the strike.
The Indian crisis has also put pressure on the Biden administration to share US health resources.
The White House said Monday that it expects about 10 million doses of the AstraZeneca vaccine to be released once the Food and Drug Administration (FDA) completes its review in the coming weeks.
It said that 50 million doses were in various stages of production.
At a news briefing, White House spokesman En Psaki said FDA officials would conduct quality checks before export.
“Our team will provide more detailed information about our planning, who will receive offers from here, but we are currently in the planning process,” he added.
The United States has already announced that it will provide raw materials to Indian vaccine manufacturers as the country fights a devastating wave of events.
During a “warm and positive” phone call with Indian Prime Minister Narendra Modi on Monday, President Biden promised more emergency assistance “including oxygen supplies, vaccines and medical supplies,” the White House said in a statement.
Washington is also looking into the delivery of oxygen to the Indian Health Service, Covid tests, personal protective equipment (PPE) and antiviral drugs.
The FDA has so far approved three vaccines against Covid-19: Pfizer BioNTech, Moderna and Johnson & Johnson (Janssen). Experts say that they are likely to meet all the needs of the country և AstraZeneca porous may not be necessary.
According to the latest data, more than 53% of adults have received at least one dose of the vaccine so far.
The United States is using “vaccine diplomacy”
The development of the coronavirus epidemic in the United States has had many drawbacks, but the production of vaccines is not one of them. The Biden administration has a wealth of resources, and now shares some of those rewards with other countries.
The decision to ship up to 60 million doses of AstraZeneca vaccine, which has yet to be approved for use in the United States, comes at a critical time. The United States, Canada, and Mexico continue to struggle, while India continues to wreak havoc. ,
This allows the Biden administration to engage in “vaccine diplomacy.” Using freight to put pressure on other nations to back down, to bring goodwill, which can help develop other US foreign policy priorities.
At the very least, it immunizes Biden with criticism that the United States has turned its back on the world by sitting on millions of doses that were not necessary or desirable when they could have saved lives.
For the president, the internal risk seems minimal as long as he maintains US supplies. It signals the administration’s growing confidence that the internal challenge ahead is not to strike hard enough, but to persuade all Americans to get vaccinated.